1) epithelial ovarian cancer/therapy
卵巢上皮癌/治疗
2) recurrent epithelial ovarian cancer/drug therapy
复发性上皮性卵巢癌/药物治疗
3) ovarian carcinoma/therapy
卵巢癌/治疗
4) epithelial ovarian cancer
卵巢上皮癌
1.
Clinical analysis of paclitaxel liposome combined with carboplatin in the treatment of advanced epithelial ovarian cancer;
紫杉醇脂质体联合卡铂治疗晚期卵巢上皮癌的临床分析
2.
Clinical significance of DNA content and cell cycle phase analysis in epithelial ovarian cancer;
卵巢上皮癌DNA含量和细胞增殖水平测定的临床意义
3.
Effect of individual treatment of recarrent epithelial ovarian cancer with ascites
复发性卵巢上皮癌腹水的个体化治疗
5) ovarian epithelial cancer
卵巢上皮癌
1.
The application value of combined detection of serum levels of OPN and CA_(125) in the diagnosis and treatment of ovarian epithelial cancer;
血清骨桥蛋白和CA_(125)联合检测在卵巢上皮癌诊疗中的应用价值
2.
The detection of serum CA125 in patients with ovarian epithelial cancer by chemical luminal immunoassay;
化学发光标记免疫测定法检测卵巢上皮癌患者血清CA125水平
6) Epithelial ovarian carcinoma
卵巢上皮癌
1.
Prognostic factors of epithelial ovarian carcinoma in patients with age under 40;
40岁以下妇女卵巢上皮癌的预后因素
2.
Objective To evaluate the effects of plasma lysophosphatidic acid(LPA)on the carcinogenesis of epithelial ovarian carcinoma and the diagnosis.
目的探讨溶血磷脂酸(lysophosphatidic acid,LPA)在卵巢上皮癌发生和发展中的作用及临床意义。
3.
Thirty-four epithelial ovarian carcinoma (EOC) patients with ascites were divided into two groups: group A (n=22) receiving preoperative chemotherapy with PAC regimen plus abdominal cavity chemotherapy 2 or 3 cycles; group B (n=12) undergoing abdominal chemotherapy only 2 cycels.
卵巢上皮癌伴腹水患者 34例 ,随机分为 2组。
补充资料：睾丸绒毛膜上皮癌
睾丸绒毛膜上皮癌
chorioepithelioma of testis
占生殖细胞瘤的1%，瘤体小，恶性度高，生长快，早期有血行转移。含有合体滋养细胞和细胞滋养层细胞两种细胞成分。常与胚胎癌、畸胎瘤和精原细胞瘤混合存在。预后较差。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条